logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 5 of 5 Items
Showing 1 - 5 of 5 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Short Report

Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research

Broger T, Marx FM, Theron G, Marais BJ, Nicol MP,  et al.
2024-07-01 • Lancet Global Health
2024-07-01 • Lancet Global Health
Journal Article
|
Commentary

Diagnostics to support the scaling up of shorter, safer tuberculosis regimens

Branigan D, Denkinger CM, Furin J, Heitkamp P, Deborggraeve S,  et al.
2023-07-31 • Lancet Microbe
2023-07-31 • Lancet Microbe
Journal Article
|
Commentary

The 1/4/6x24 campaign to cure tuberculosis quickly

McKenna L, Frick M, Angami K, Dubula V, Furin J,  et al.
2023-01-01 • Nature Medicine
2023-01-01 • Nature Medicine
Journal Article
|
Research

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bayona J,  et al.
2012-08-28 • PLOS Medicine
2012-08-28 • PLOS Medicine
Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data meta-analysis to assess the ...
Journal Article
|
Short Report

Defining the Needs for Next Generation Assays for Tuberculosis

Denkinger CM, Kik S, Cirillo DM, Casenghi M, Shinnick T,  et al.
2015-04-01 • Journal of Infectious Diseases
2015-04-01 • Journal of Infectious Diseases
To accelerate the fight against tuberculosis, major diagnostic challenges need to be addressed urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics tha...